Table 1 Clinical characteristics of patients with ARDS
|  | All patients (n = 24) |
|---|---|
Age (years) | 76.5 (59.8–84.5) |
Male | 17 (70.8) |
APACHE II score on Day 1 | 26.0 (23.0–28.0) |
SOFA score on Day 1 | 8.5 (6.0–10.8) |
History | |
 Chronic obstructive pulmonary disease | 5 (20.8) |
 Heart failure | 1 (4.2) |
 Hypertension | 11 (45.8) |
 Diabetes mellitus | 9 (37.5) |
 Previous cerebral vascular accident | 5 (20.8) |
 End stage renal disease | 0 (0.0) |
 Liver cirrhosis | 1 (4.2) |
 Active malignancy | 1 (4.2) |
Adverse event | |
 New arrhythmia | 2 (8.3) |
 Gastrointestinal bleeding | 5 (20.8) |
 Acute kidney injury | 8 (33.3) |
 Shock | 7 (29.2) |
 Thrombocytopenia | 7 (29.2) |
 Jaundice | 3 (12.5) |
 Bacteremia | 4 (16.7) |
PaO2/FiO2 ratio (mm Hg) | 134.4 (107.6–191.5) |
 Mild, 200 < PaO2/FiO2 ≤ 300 | 5 (20.8) |
 Moderate, 100 < PaO2/FiO2 ≤ 200 | 16 (66.7) |
 Severe, PaO2/FiO2 ≤ 100 | 3 (12.5) |
Management | |
 Glucocorticoid | 7 (29.2) |
 Vasopressor | 7 (29.2) |
 Prone ventilation | 2 (8.3) |
 Extracorporeal membrane oxygenation | 0 (0.0) |
Pathogen detected in airway | |
 Stenotrophomonas maltophilia | 2 (8.3) |
 Influenza virus | 2 (8.3) |
 Staphylococcus aureus | 1 (4.2) |
 Acinetobacter baumannii | 1 (4.2) |
 Klebsiella pneumoniae | 1 (4.2) |
 Escherichia coli | 1 (4.2) |
 Enterobacter species | 1 (4.2) |
 Candida species | 1 (4.2) |
 Streptococcus pneumoniae | 1 (4.2) |
APACHE II score on Day 8 | 23.0 (17.3–27.0) |
SOFA score on Day 8 | 5.5 (3.0–9.0) |
28Â day mortality | 1 (4.2) |